CoChat

Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2

Open access
Vogels, Chantal B. F., Breban, Mallery I., Ott, Isabel M., Alpert, Tara, Petrone, Mary E., Watkins, Anne E., Kalinich, Chaney C., Earnest, Rebecca, Rothman, Jessica E., Goes de Jesus, Jaqueline, Morales Claro, Ingra, Magalhães Ferreira, Giulia, Crispim, Myuki A. E., Brazil-UK CADDE Genomic Network, Singh, Lavanya, Tegally, Houriiyah, Anyaneji, Ugochukwu J., Network for Genomic Surveillance in South Africa, Hodcroft, Emma B., Mason, Christopher E., Khullar, Gaurav, Metti, Jessica, Dudley, Joel T., MacKay, Matthew J., Nash, Megan, Wang, Jianhui, Liu, Chen, Hui, Pei, Murphy, Steven, Neal, Caleb, Laszlo, Eva, Landry, Marie L., Muyombwe, Anthony, Downing, Randy, Razeq, Jafar, de Oliveira, Tulio, Faria, Nuno R., Sabino, Ester C., Neher, Richard A., Fauver, Joseph R., Grubaugh, Nathan D. · 2021 · PLOS Biology

Published version of a preprint

Cited by 226

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

With the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants that may increase transmissibility and/or cause escape from immune responses, there is an urgent need for the targeted surveillance of circulating lineages. It was found that the B.1.1.7 (also 501Y.V1) variant, first detected in the United Kingdom, could be serendipitously detected by the Thermo Fisher TaqPath COVID-19 PCR assay because a key deletion in these viruses, spike Δ69–70, would cause a “spike gene target failure” (SGTF) result. However, a SGTF result is not definitive for B.1.1.7, and this assay cannot detect other variants of concern (VOC) that lack spike Δ69–70, such as B.1.351 (also 501Y.V2), detected in South Africa, and P.1 (also 501Y.V3), recently detected in Brazil. We identified a deletion in the ORF1a gene (ORF1a Δ3675–3677) in all 3 variants, which has not yet been widely detected in other SARS-CoV-2 lineages. Using ORF1a Δ3675–3677 as the primary target and spike Δ69–70 to differentiate, we designed and validated an open-source PCR assay to detect SARS-CoV-2 VOC. Our assay can be rapidly deployed in laboratories around the world to enhance surveillance for the local emergence and spread of B.1.1.7, B.1.351, and P.1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.3001236

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 10

  1. NG Davies, 2020, Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England., medRxiv
  2. A Rambaut, 2020, Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations
  3. M Kidd, 2020, S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-QPCR., medRxiv.
  4. SE Galloway, 2021, Emergence of SARS-CoV-2 B.1.1.7 Lineage—United States, December 29, 2020-January 12, 2021., MMWR Morb Mortal Wkly Rep., 70, 95, 10.15585/mmwr.mm7003e2 · DOI · Paper page
  5. X Lu, 2020, US CDC real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2, Emerg Infect Dis, 26
  6. E Kudo, 2020, Detection of SARS-CoV-2 RNA by multiplex RT-qPCR., bioRxiv
  7. C Vogels, 2021, Multiplexed RT-qPCR to screen for SARS-COV-2 B.1.1.7, B.1.351, and P.1 variants of concern v3. protocols.io.
  8. E Lasek-Nesselquist, 2021, The localized rise of a B.1.526 variant containing an E484K mutation in New York State., medRxiv.
  9. J. Quick, 2020, nCoV-2019 sequencing protocol v3
  10. JR Tyson, 2020, Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore, Cold Spring Harb Laboratory

Cited by

Metadata

Authors
Vogels, C. B. F., Breban, M. I., Ott, I. M., Alpert, T., Petrone, M. E., Watkins, A. E., Kalinich, C. C., Earnest, R., Rothman, J. E., Goes de Jesus, J., Morales Claro, I., Magalhães Ferreira, G., Crispim, M. A. E., Brazil-UK CADDE Genomic Network, Singh, L., Tegally, H., Anyaneji, U. J., Network for Genomic Surveillance in South Africa, Hodcroft, E. B., Mason, C. E., Khullar, G., Metti, J., Dudley, J. T., MacKay, M. J., Nash, M., Wang, J., Liu, C., Hui, P., Murphy, S., Neal, C., Laszlo, E., Landry, M. L., Muyombwe, A., Downing, R., Razeq, J., de Oliveira, T., Faria, N. R., Sabino, E. C., Neher, R. A., Fauver, J. R., & Grubaugh, N. D.
Venue
PLOS Biology
Published
2021-05-07
Volume
19
Issue
5
Pages
e3001236
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W3159242440
Cited by
226
References
15
FWCI
15.62
Type
journal article
Language
en
Open access
gold
Funders
  • CTSA (TL1 TR001864)
  • Wellcome Trust and Royal Society Sir Henry Dale Fellowship (204311/Z/16/Z)
  • Medical Research Council-São Paulo Research Foundation CADDE partnership award (MR/S0195/1 and FAPESP 18/14389-0)
  • Fast Grant from Emergent Ventures at the Mercatus Center at George Mason University
  • Centers for Disease Control and Prevention (75D30120C09570)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.